Cancer prevention drug trials are to go ahead
The controversial research trial has been approved by the Department of Health even though the Medical Research Council refused to fund the study because of worries that the drug, tamoxifen, may increase the risk of liver cancer and because little is known about its long-term effect on well women. Other studies pointed to an increased risk of cancer of the womb.
But, if successful, the use of tamoxifen should reduce the number of breast cancers by 150 among the women in the trial. In the population it could reduce the number of new cancers by 1,500 a year. Breast cancer is the biggest single cancer killer of women in Britain, which has the highest death rate from the disease in the world. Every year 15,300 British women die from the disease and 27,000 new cases are diagnosed.
Over the coming months 15,000 women with no disease will be recruited and given tamoxifen or a placebo for five years. They will be monitored for 10 years. Ten to 15 per cent of the women will be aged 35 to 44 and have a high risk of the disease, with a mother or sister having had cancer in both breasts by the time they were 40. But the majority in the trial will be older, aged 45 to 65, and have a smaller increased risk because of family history of breast cancer or other factors.
Tamoxifen has a proven record in reducing the recurrence of breast cancer in women previously treated for breast cancer who are more at risk. It has been used by thousands of women amounting to 'millions of women years' of experience worldwide, say the researchers.
It is a complex drug which inhibits the action of the female hormone oestrogen. A pilot study in preventing breast cancer has revealed some unexpected benefits including lower blood cholesterol levels and improved bone strength in older women.
The study costing pounds 5m, is funded by the Imperial Cancer Research Fund and the Cancer Research Campaign and organised by the United Kingdom Co- ordinating Committee on Cancer Research.
Announcing the approval of the Department of Health, Dame Margaret Turner-Warwick, chairman of the UKCCCR, said it was a major initiative in which women would be given the fullest information about the possible benefits and risks.
Dr Trevor Powles, of the Royal Marsden Hospital, has led the pilot study for the trial. To date, 2,000 well women who have been followed for a maximum of 7.5 years. 'At first I was worried about recruiting women. But when we started to see the cholesterol levels coming down and the women not losing bone I felt a lot more comfortable.'
The Medical Research Council is conducting its own studies of the effects of tamoxifen, particularly in relation to cancer of the liver. Dr Lewis Smith, director of the MRC Toxicology Unit in Leicester, which is conducting the tests, said: 'We do not know what will happen to a normal population of women, with no breast cancer, over long periods of time,' he said.
Ian McKellen and Patrick Stewart bromance continues: X-Men star gushes about 'pussy cat' BFF Patrick Stewart
David Cameron stung by jellyfish: PM hurt after ignoring advice of locals while on holiday
South Korea ferry: Vice principal rescued from sinking ship found hanged
Catherine Deneuve and Sophie Marceau in war of words over President Francois Hollande's affair with Julie Gayet
Inside North Korea with the man who won the marathon
The food poverty scandal that shames Britain: Nearly 1m people rely on handouts to eat – and benefit reforms may be to blame
US Navy christens huge $3 billion destroyer ship USS Zumwalt that appears as a fishing boat on enemy radar
Scottish independence: It is the English who should be on their knees, begging the Scots to vote ‘No’
Nigel Farage fatigue? Half of voters ‘immune’ to Ukip’s appeal
Nigel Farage: I’m taking on the status quo, and the Establishment’s fighting back
Refugee facing deportation from Sweden saved by fellow passengers refusing to let plane leave
- 1 KFC 'sorry' after lesbian couple are kicked out of Bath restaurant for 'heavy petting'
- 2 West Ham confirm 20-year-old striker Dylan Tombides has died after battle with cancer
- 3 24 people applied for the 'world's toughest job', here are their interviews
- 4 Video of British Muslims dancing to Pharrell Williams's hit Happy attacked as 'sinful'
- 5 PFA Player of the Year: Luis Suarez, Daniel Sturridge and Steven Gerrard all nominated as Liverpool dominate award shortlist
£150.00 per week: QA Apprenticeships: This company is a company that specializ...
£153.75 per week: QA Apprenticeships: This company is an innovative outsourcin...
£150.00 per week: QA Apprenticeships: This company has been providing on site ...
£150.00 per week: QA Apprenticeships: We've been supplying best of breed peopl...